Gene · 10253
Papers1,626
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,626
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Retinoblastoma-Binding Protein 5 Regulates H3K4 Methylation Modification to Inhibit the Proliferation of Melanoma Cells by Inactivating the Wnt/β-Catenin and Epithelial-Mesenchymal Transition Pathways. | J Oncol | 2023 | 36866240 | PubTator, text mining | PubMed |
| Oxidative stress and epigenetics in ocular vascular aging: an updated review. | Mol Med | 2023 | 36849907 | PubTator, text mining | PubMed |
| Critical Review on the Different Roles of Exosomes in TNBC and Exosomal-Mediated Delivery of microRNA/siRNA/lncRNA and Drug Targeting Signalling Pathways in Triple-Negative Breast Cancer. | Molecules | 2023 | 36838790 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Exosomes Enhance 3D-Printed Scaffold Functions and Promote Alveolar Bone Defect Repair by Enhancing Angiogenesis. | J Pers Med | 2023 | 36836414 | PubTator, text mining | PubMed |
| MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer. | Cancers (Basel) | 2023 | 36831632 | PubTator, text mining | PubMed |
| Current Strategies for Promoting the Large-scale Production of Exosomes. | Curr Neuropharmacol | 2023 | 36797614 | PubTator, text mining | PubMed |
| Insights into the Molecular Mechanisms Regulating Cell Behavior in Response to Magnetic Materials and Magnetic Stimulation in Stem Cell (Neurogenic) Differentiation. | Int J Mol Sci | 2023 | 36768351 | PubTator, text mining | PubMed |
| Integrative competing endogenous RNA network analyses identify novel lncRNA and genes implicated in metastatic breast cancer. | Sci Rep | 2023 | 36765262 | PubTator, text mining | PubMed |
| Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells. | Acta Neuropathol Commun | 2023 | 36750863 | PubTator, text mining | PubMed |
| Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2. | PLoS One | 2023 | 36749775 | PubTator, text mining | PubMed |
| The endothelial-enriched lncRNA LINC00607 mediates angiogenic function. | Basic Res Cardiol | 2023 | 36700983 | PubTator, text mining | PubMed |
| Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance. | Mol Syst Biol | 2023 | 36700386 | PubTator, text mining | PubMed |
| Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis. | Genet Res (Camb) | 2023 | 36688087 | PubTator, text mining | PubMed |
| Evaluation of Arterial Histopathology and microRNA Expression That Underlie Ultrasonography Findings in Temporal Arteries of Patients with Giant Cell Arteritis. | Int J Mol Sci | 2023 | 36675088 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 36674820 | PubTator, text mining | PubMed |
| Synovial Fluid Derived from Human Knee Osteoarthritis Increases the Viability of Human Adipose-Derived Stem Cells through Upregulation of FOSL1. | Cells | 2023 | 36672268 | PubTator, text mining | PubMed |
| A topographic atlas defines developmental origins of cell heterogeneity in the human embryonic lung. | Nat Cell Biol | 2023 | 36646791 | PubTator, text mining | PubMed |
| Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status. | J Ovarian Res | 2023 | 36611214 | PubTator, text mining | PubMed |
| Craniosynostosis, inner ear, and renal anomalies in a child with complete loss of SPRY1 (sprouty homolog 1) function. | J Med Genet | 2023 | 36543535 | PubTator, text mining | PubMed |
| DNA methylation in cell plasticity and malignant transformation in liver diseases. | Pharmacol Ther | 2023 | 36535346 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10253/papers?page=8